Haiwen Li Selected Research

Haiwen Li Research Topics

Disease

14	Neoplasms (Cancer) 04/2024 - 12/2014
5	Nasopharyngeal Carcinoma 02/2023 - 12/2014
3	Inflammation (Inflammations) 08/2024 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 06/2021
3	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2022
3	Stomach Neoplasms (Stomach Cancer) 02/2024 - 01/2020
3	Carcinogenesis 06/2021 - 01/2019
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 01/2019
3	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2016
2	Wounds and Injuries (Trauma) 08/2024 - 12/2022
2	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 01/2021
2	Metaplasia 01/2024 - 12/2020
2	Muscular Dystrophies (Muscular Dystrophy) 01/2023 - 09/2020
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2023 - 12/2021
2	Hypoxia (Hypoxemia) 10/2020 - 08/2017
1	Bacterial Infections (Bacterial Infection) 08/2024
1	Respiratory Syncytial Virus Infections 04/2024
1	Atrophy 01/2024
1	Glioma (Gliomas) 10/2023
1	Ovarian Neoplasms (Ovarian Cancer) 10/2023
1	Hypercholesterolemia 06/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023
1	Obesity 01/2023
1	ST Elevation Myocardial Infarction 01/2023
1	Infections 12/2022
1	Lymphatic Metastasis 01/2022
1	Pain (Aches) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	COVID-19 06/2021
1	Colitis 01/2021

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2020
3	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
3	Cisplatin (Platino)FDA LinkGeneric 02/2023 - 01/2016
3	Niclosamide FDA Link 01/2018 - 08/2017
2	ChitosanIBA 08/2024 - 12/2020
2	HydrogelsIBA 08/2024 - 12/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2024 - 01/2021
2	CytokinesIBA 08/2023 - 09/2020
2	LipidsIBA 06/2023 - 01/2023
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 01/2021
2	Ion Channels (Ion Channel)IBA 01/2023 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 08/2017
2	PolyphenolsIBA 01/2020 - 05/2019
1	Metal-Organic FrameworksIBA 08/2024
1	Gallic AcidIBA 08/2024
1	Ammonium CompoundsIBA 08/2024
1	SaltsIBA 08/2024
1	MagnesiumIBA 08/2024
1	AlginatesIBA 08/2024
1	AntioxidantsIBA 08/2024
1	CollagenIBA 08/2024
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2024
1	TeaIBA 04/2024
1	Toll-Like Receptor 4IBA 04/2024
1	NucleolinIBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 04/2024
1	fibroblast growth factor 13IBA 02/2024
1	Circular RNAIBA 02/2024
1	spasmolytic polypeptideIBA 01/2024
1	si-jun-zi-tangIBA 01/2024
1	Complement System Proteins (Complement)IBA 10/2023
1	Interferon Type IIBA 08/2023
1	SolutionsIBA 06/2023
1	Angiopoietin-like ProteinsIBA 06/2023
1	Plasma GasesIBA 05/2023
1	tislelizumabIBA 02/2023
1	Therapeutic UsesIBA 02/2023
1	130-nm albumin-bound paclitaxelIBA 02/2023
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2023
1	Hyaluronic Acid (Hyaluronan)IBA 12/2022
1	polydopamineIBA 12/2022
1	Capsules (Microcapsules)IBA 12/2022
1	AntigensIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2021
1	AnoctaminsIBA 12/2021
1	MicroRNAs (MicroRNA)IBA 06/2021
1	Competitive Endogenous RNAIBA 06/2021
1	Antiviral Agents (Antivirals)IBA 06/2021
1	EmetineIBA 06/2021
1	AzoxymethaneIBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Galectin 2 (LGALS2)IBA 01/2021
1	ParvalbuminsIBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 02/2024 - 01/2018
3	Therapeutics 05/2023 - 01/2016
3	Immunotherapy 02/2023 - 01/2022
2	Chemoradiotherapy 02/2023 - 01/2022
2	Radiotherapy 04/2015 - 12/2014
1	Nanospheres 04/2024
1	Induction Chemotherapy 02/2023
1	Injections 12/2022
1	Ostomy 09/2022
1	Aftercare (After-Treatment) 01/2022